8/1/2013 6:21:40 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SEATTLE, July 31, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the second quarter and six months ended June 30, 2013.
"The second quarter was highlighted by the substantial progress we made in our reimbursement discussions for PIXUVRI® (pixantrone) in Europe, specifically in the UK and Italy," said James Bianco, M.D., President and CEO of CTI.
Help employers find you! Check out all the jobs and post your resume.
comments powered by